Latest Licensing News

Perpetual Resources has completed a transformational acquisition of three lithium projects in Brazil’s Lithium Valley, confirming high-grade spodumene mineralisation and advancing drilling plans for Q2 2025. Metallurgical tests at its Raptor Rare Earth Project show strong recoveries of critical magnet rare earth elements.

Argent BioPharma reports significant operational savings through manufacturing outsourcing, encouraging Phase IIb results for CimetrA®, and key regulatory approvals for cannabinoid therapies in Germany.

Patrys Limited advances its PAT-DX3 therapy development for inflammatory diseases while navigating cash flow challenges and pursuing partnerships to sustain operations.

Starpharma reports steady progress in its DEP® drug development programs, launches new marketing campaigns in key regions, and maintains a strong cash position of $17.2 million as it refines clinical strategies and partnerships.

Uvre Limited reported steady progress in its uranium and lithium exploration projects during the March 2025 quarter, completing Phase 2 geophysical surveys and advancing joint venture discussions while maintaining solid cash reserves.

TG Metals Limited has secured an 80% stake in the Van Uden Gold Project in Western Australia, setting the stage for renewed exploration and resource evaluation. The company is poised to unlock near-term production potential through drilling and stockpile assessments.

Axel REE Limited advances its flagship Caladão REE-Gallium Project with significant high-grade intercepts and begins a maiden Mineral Resource Estimate, backed by $9.6 million in cash and strategic government partnerships.

Terra Metals has made significant strides at its Dante polymetallic project, producing three high-grade concentrates and extending mineralisation, while securing a strategic tenement option to expand its resource base.

Microba Life Sciences reported robust Q3 FY25 growth in its microbiome diagnostic tests, led by MetaXplore and MetaPanel, while advancing its therapeutics pipeline and projecting strong full-year revenue growth.

Microba Life Sciences reports robust growth in microbiome diagnostic testing across Australia and the UK, while advancing US market entry plans and transitioning its Therapeutics business to a partnering model.

Gold Hydrogen Limited is gearing up for a pivotal 2025 drilling campaign at its Ramsay Project, aiming to further appraise significant natural hydrogen and helium accumulations confirmed in prior exploration. The company also bolsters its technical team and launches a new InvestorHub to deepen stakeholder engagement.

Percheron Therapeutics has discontinued its ATL1103 program and curtailed investment in ATL1102 following underwhelming trial results, while advancing talks to in-license new rare disease therapies and extending its cash runway into FY2027.